Genesis Capital Acquires a 75 Percent Stake in Quinta-Analytica (CEE and CIS)

Czech Republic- and Slovakia-focused private equity firm Genesis Capital has acquired a 75 percent stake in Czech Republic-based Quinta-Analytica, a commercial services provider for the pharmaceutical, biotechnology and generic drug industries. Financial details of the transaction, which was structured through Genesis Private Equity Fund III, were not disclosed. Read More

Omidyar Network Participates in Financing Rounds for IntelleGrow and NowFloats (Asia)

Philanthropic investment firm Omidyar Network, asset manager Developing World Markets (DWM) and European lender Triodos Bank’s investment arm Triodos Investment Management have invested INR510 million (approximately US$7.6 million) in India-based venture debt lender Jain Sons Finlease, which operates under the IntelleGrow brand. Omidyar invested INR150 million (approximately US$2.2 million), while… Read More

Nexxus Capital Invests in Fondo de Transporte México (Latin America)

Mexico-focused private equity firm Nexxus Capital has agreed to invest in Mexico-based Fondo de Transporte México, a holding company focused on the logistics, cargo, personnel and student transportation sectors. The transaction will be structured though Nexxus Capital VI. Financial details of the transaction, which is pending certain closing conditions including… Read More

Mediterrania Capital Partners Invests in MedTech Group (MENA)

North Africa-focused private equity firm Mediterrania Capital Partners has invested in Morocco-based IT business system integrator MedTech Group. The transaction was structured through Mediterrania Capital II. MedTech operates in the software, hardware and middleware infrastructure, payment solutions, and telecom and network systems sectors. Financial details of the transaction were not… Read More

Warburg Pincus Agrees to Sell a Partial Stake in China Biologic Products (Asia)

Global private equity firm Warburg Pincus has agreed to sell a 10.4 percent stake in NASDAQ-listed blood plasma-based biopharmaceutical company China Biologic Products in an underwritten public offering. Warburg Pincus, which originally invested in Biologic through Warburg Pincus Private Equity X, will sell 2.78 million shares. The offering is expected… Read More



(default archive template)